● Covered by 2 sources · 2 reportsMedium impact2 negative
Amgen Discloses Data Breach Affecting Patient Health and Proprietary Information
Key points
- Amgen detected unauthorized activity in July 2026.
- Data was stolen from third-party cloud environments.
- Exfiltrated data includes proprietary information and patient health data.
- Investigation is ongoing to determine full extent of data loss.
- Amgen plans to notify affected individuals.
Overview of the Incident
Pharmaceutical company Amgen has disclosed a data breach involving the theft of corporate data and patient information. The incident occurred within multiple cloud systems managed by third-party service providers.
Unauthorized activity was first detected in July 2026. Amgen responded by activating its cybersecurity response plan, implementing containment measures, and engaging independent forensic experts to investigate the breach.
Nature of the Stolen Data
The investigation has confirmed that attackers exfiltrated sensitive data from the cloud environments. This includes proprietary company data, protected health information belonging to patients, and other sensitive records.
Amgen is still assessing whether additional confidential business information, intellectual property, research and development data, or further patient information was accessed or stolen.
Company Response and Impact Assessment
Amgen, a California-based biotechnology company specializing in medicines for serious illnesses, stated that it has not identified any disruption to its products, manufacturing operations, financial reporting systems, or its ability to supply medicines to patients.
The company also indicated that the incident is not reasonably likely to have a material impact on its financial condition or results of operations. Amgen plans to notify affected individuals as the investigation progresses.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
How outlets covered it
Biotech company Amgen announced that patient information and proprietary company data were stolen from cloud systems operated by external service providers. The incident, detected in July, involved unauthorized activity and exfiltration of sensitive records, prompting Amgen to plan notifications for affected patients.
Pharmaceutical company Amgen disclosed a data breach where threat actors stole corporate and patient data from multiple third-party cloud systems. The breach, detected in July 2026, involved the exfiltration of proprietary data and protected health information, prompting an ongoing investigation and evaluation of notification requirements.